Researcher.Life Logo

Expert Review of Clinical Pharmacology : Impact Factor & More

eISSN: 1751-2441pISSN: 1751-2433

Aims and Scope of Expert Review of Clinical Pharmacology

Expert Review of Clinical Pharmacology is a monthly peer-reviewed medical journal covering all aspects of clinical pharmacology published by Taylor & Francis. The journal is abstracted and indexed in Chemical Abstracts, EMBASE/Excerpta Medica, MEDLINE/Index Medicus/PubMed, and Scopus. Its a state of the art journal focussing on all aspects of clinical pharmacology and accepts both original researches as well as reviews. The journal has a rigorous peer-review process. The extensive peer review is known to improve the quality of the manuscript to a significant extent. The journal publishes most of the time almost instantly upon acceptance with a normal turnaround time of <72 hours. The current Commissioning Editor is Jermaine Wilcock... Less

Key Metrics

CiteScore
6.8
Eigenfactor
0.001 - 0.005
H-Index
53
Impact Factor
< 5
SJR
Q1Pharmacology (medical)
SNIP
1.18
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Expert Review of Clinical Pharmacology

Expert Review of Clinical Pharmacology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2008
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Expert Review of Clinical Pharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Expert Review of Clinical Pharmacology

Novel biomarkers driving treatment selection in metastatic castration-sensitive prostate cancer: fundamentals of personalized clinical decision making.
  • 19 May 2026
  • Expert review of clinical pharmacology
Factors to consider when designing clinical trials for repurposed drugs
  • 10 May 2026
  • Expert Review of Clinical Pharmacology
Immunotherapy in limited-stage small cell lung cancer: riding the ADRIATIC wave toward precision
  • 4 May 2026
  • Expert Review of Clinical Pharmacology
Potential beneficial effect of treatment with PCSK9 inhibitors on vascular endothelial dysfunction: a systematic review and meta-analysis
  • 4 May 2026
  • Expert Review of Clinical Pharmacology
Developing treatment strategies to optimize outcomes in patients with psoriatic arthritis
  • 4 May 2026
  • Expert Review of Clinical Pharmacology
Osteoarthritis and dementia: contrasting disorders driven by mutual pathways of autophagy, mTOR, GLP-1, AMPK, Wnt, and WISP1
  • 4 May 2026
  • Expert Review of Clinical Pharmacology
Novel biomarkers driving treatment selection in metastatic castration-sensitive prostate cancer: fundamentals of personalized clinical decision making.
  • 19 May 2026
  • Expert review of clinical pharmacology
Factors to consider when designing clinical trials for repurposed drugs
  • 10 May 2026
  • Expert Review of Clinical Pharmacology
Immunotherapy in limited-stage small cell lung cancer: riding the ADRIATIC wave toward precision
  • 4 May 2026
  • Expert Review of Clinical Pharmacology
Potential beneficial effect of treatment with PCSK9 inhibitors on vascular endothelial dysfunction: a systematic review and meta-analysis
  • 4 May 2026
  • Expert Review of Clinical Pharmacology
Developing treatment strategies to optimize outcomes in patients with psoriatic arthritis
  • 4 May 2026
  • Expert Review of Clinical Pharmacology
Osteoarthritis and dementia: contrasting disorders driven by mutual pathways of autophagy, mTOR, GLP-1, AMPK, Wnt, and WISP1
  • 4 May 2026
  • Expert Review of Clinical Pharmacology

FAQs on Expert Review of Clinical Pharmacology